Search research articles
Contact Us
Filters
Showing results (71-80 of 105) with videos related to
Page
of 11
Sort By:
The New England Journal of Medicine
|
November 15, 2002
Cyclin E and survival in patients with breast cancer
Khandan Keyomarsi, Susan L Tucker, Thomas A Buchholz, et al.
Nature Communications
|
February 5, 2016
PAF-Wnt signaling-induced cell plasticity is required for maintenance of breast cancer cell stemness
Xin Wang, Youn-Sang Jung, Sohee Jun, et al.
Cancers
|
March 22, 2020
Cytoplasmic Cyclin E Is an Independent Marker of Aggressive Tumor Biology and Breast Cancer-Specific Mortality in Women over 70 Years of Age
Simon J Johnston, Binafsha M Syed, Ruth M Parks, et al.
Cancer Research
|
February 12, 2005
The low molecular weight cyclin E isoforms augment angiogenesis and metastasis of human melanoma cells in vivo
Elise Bales, Lisa Mills, Nancy Milam, et al.
Molecular Cancer Research : MCR
|
September 28, 2016
AXL Inhibition Suppresses the DNA Damage Response and Sensitizes Cells to PARP Inhibition in Multiple Cancers
Kavitha Balaji, Smruthi Vijayaraghavan, Lixia Diao, et al.
Oncogenesis
|
May 15, 2021
LMW cyclin E and its novel catalytic partner CDK5 are therapeutic targets and prognostic biomarkers in salivary gland cancers
Amriti R Lulla, Said Akli, Cansu Karakas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 20, 2007
The double-stranded RNA-activated protein kinase mediates radiation resistance in mouse embryo fibroblasts through nuclear factor kappaB and Akt activation
Urs von Holzen, Abujiang Pataer, Uma Raju, et al.
Journal of Cancer
|
August 19, 2017
Rapid Breast Cancer Disease Progression Following Cyclin Dependent Kinase 4 and 6 Inhibitor Discontinuation
Sami I Bashour, Iman Doostan, Khandan Keyomarsi, et al.
Annals of Surgery
|
August 23, 2019
Cytoplasmic Cyclin E Expression Predicts for Response to Neoadjuvant Chemotherapy in Breast Cancer
Cansu Karakas, Ashleigh M Francis, Min Jin Ha, et al.
Cancers
|
April 30, 2021
Targeting Replicative Stress and DNA Repair by Combining PARP and Wee1 Kinase Inhibitors Is Synergistic in Triple Negative Breast Cancers with Cyclin E or <i>BRCA1</i> Alteration
Xian Chen, Dong Yang, Jason P W Carey, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 105) with videos related to
Sort By:
Page
of 11
The New England Journal of Medicine
|
November 15, 2002
Cyclin E and survival in patients with breast cancer
Khandan Keyomarsi, Susan L Tucker, Thomas A Buchholz, et al.
Nature Communications
|
February 5, 2016
PAF-Wnt signaling-induced cell plasticity is required for maintenance of breast cancer cell stemness
Xin Wang, Youn-Sang Jung, Sohee Jun, et al.
Cancers
|
March 22, 2020
Cytoplasmic Cyclin E Is an Independent Marker of Aggressive Tumor Biology and Breast Cancer-Specific Mortality in Women over 70 Years of Age
Simon J Johnston, Binafsha M Syed, Ruth M Parks, et al.
Cancer Research
|
February 12, 2005
The low molecular weight cyclin E isoforms augment angiogenesis and metastasis of human melanoma cells in vivo
Elise Bales, Lisa Mills, Nancy Milam, et al.
Molecular Cancer Research : MCR
|
September 28, 2016
AXL Inhibition Suppresses the DNA Damage Response and Sensitizes Cells to PARP Inhibition in Multiple Cancers
Kavitha Balaji, Smruthi Vijayaraghavan, Lixia Diao, et al.
Oncogenesis
|
May 15, 2021
LMW cyclin E and its novel catalytic partner CDK5 are therapeutic targets and prognostic biomarkers in salivary gland cancers
Amriti R Lulla, Said Akli, Cansu Karakas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 20, 2007
The double-stranded RNA-activated protein kinase mediates radiation resistance in mouse embryo fibroblasts through nuclear factor kappaB and Akt activation
Urs von Holzen, Abujiang Pataer, Uma Raju, et al.
Journal of Cancer
|
August 19, 2017
Rapid Breast Cancer Disease Progression Following Cyclin Dependent Kinase 4 and 6 Inhibitor Discontinuation
Sami I Bashour, Iman Doostan, Khandan Keyomarsi, et al.
Annals of Surgery
|
August 23, 2019
Cytoplasmic Cyclin E Expression Predicts for Response to Neoadjuvant Chemotherapy in Breast Cancer
Cansu Karakas, Ashleigh M Francis, Min Jin Ha, et al.
Cancers
|
April 30, 2021
Targeting Replicative Stress and DNA Repair by Combining PARP and Wee1 Kinase Inhibitors Is Synergistic in Triple Negative Breast Cancers with Cyclin E or <i>BRCA1</i> Alteration
Xian Chen, Dong Yang, Jason P W Carey, et al.
Page
of 11